The emerging role of nimotuzumab in the treatment of non-small cell lung cancer

Overview of attention for article published in Biologics: Targets & Therapy, November 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#47 of 284)
High Attention Score compared to outputs of the same age (83rd percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 22 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 28 publications that cite this research output.

28

The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.

Synthesis of 111In-p-SCN-Bn-DTPA-nimotuzumab and its preclinical evaluation in EGFR positive NSCLC animal model

Article in Radiochimica Acta (October 2021)

Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents

Article in Translational Lung Cancer Research (April 2021)

Long-Term Results of Concurrent Chemoradiotherapy Combined with Anti-EGFR Monoclonal Antibody Prior to Surgery in Locally Advanced Cervical Cancer: A Single-Institute Prospective Study

Article in Cancer Management and Research (December 2020)